AG00IAQ8

60628-96-8 | 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-

AG00IAQ8

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	60628-96-8
Catalog Number	AG00IAQ8(AGN-PC-00K0SO)
Chemical Name	1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-
EC Number	262-336-6
IUPAC Name	1-[phenyl-(4-phenylphenyl)methyl]imidazole
InChI	InChI=1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H
InChI Key	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
MDL Number	MFCD00865567
Molecular Formula	C22H18N2
Molecular Weight	310.3917
NSC Number	758954
SMILES	c1ccc(cc1)c1ccc(cc1)C(n1ccnc1)c1ccccc1
Synonyms	1-((4-biphenylyl)-phenylmethyl)-1H-imidazole, Amycor, Bay H 4502, Bay H-4502, Bifokey, Bifomyk, Bifon, bifonazole, Moldina, Mycospor, bifonazole, 60628-96-8, Mycospor, Trifonazole, Bifonazol, Bifonazolum, BAY H 4502, Amycor, Azolmen, Bifonazol [INN-Spanish], Bifonazolum [INN-Latin], 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole, 1-(alpha-(4-Biphenylyl)benzyl)imidazole, 1-[phenyl-(4-phenylphenyl)methyl]imidazole, (+-)-1-(p,alpha-Diphenylbenzyl)imidazole, Bay-h-4502, 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-, 1-(p,alpha-Diphenylbenzyl)imidazole, EINECS 262-336-6, 1-[4,alpha-Diphenylbenzyl]-imidazole, BRN 0618427, 1-([1,1'-Biphenyl]-4-yl(phenyl)methyl)-1H-imidazole, MLS000028576, CHEMBL277535, CHEBI:78692, 1-[biphenyl-4-yl(phenyl)methyl]-1H-imidazole, OCAPBUJLXMYKEJ-UHFFFAOYSA-N, C22H18N2, Bifonazole, 98%, MFCD00865567, 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole, NCGC00018254-03, CPD000058970, SMR000058970, Imidazole, 1-(alpha-(4-biphenylyl)benzyl)-, 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole, 1-[phenyl(4-phenylphenyl)methyl]-1H-imidazole, DSSTox_CID_25631, DSSTox_RID_81013, DSSTox_GSID_45631, (R)-1-([1,1'-biphenyl]-4-yl(phenyl)methyl)-1H-imidazole, 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+-)-, Mycospor (TN), Bay H-4502, CAS-60628-96-8, (+/-)-Bifonazole, Bifonazole [USAN:BAN:INN:JAN], SR-01000003136, 1-(BIPHENYL-4-YL(PHENYL)METHYL)-1H-IMIDAZOLE, Mycosporan, Bedriol, Bifonazole,(S), Bifonazole [USAN:INN:BAN:JAN], AC1L1DJN, Opera_ID_1656, Spectrum2_000035, Spectrum3_001970, (.+/-.)-Bifonazole, cid_2378, SCHEMBL36803, BSPBio_003570, 5-23-04-00292 (Beilstein Handbook Reference), MLS000759537, MLS001074074, MLS001424050, SPECTRUM1505309, SPBio_000129, IMI028, Bifonazole (JP17/USAN/INN), Bifonazole, >=98% (HPLC), DTXSID9045631, CTK8F8126, KBio3_002922, KS-00000XNE, HMS1922B18, HMS2051F04, HMS2090K13, HMS2093B09, HMS2232J24, HMS3374H02, HMS3393F04, HMS3651G21, HMS3715L21, Pharmakon1600-01505309, BCP22297, HY-B0301, Tox21_110850, BDBM50128548, CCG-39996, DL-338, KM0422, NSC758954, s1854, STK618771, AKOS005553008, Tox21_110850_1, AB07497, BCP9000410, CCG-100993, CS-2335, DB04794, KS-5111, MCULE-1275076931, NC00243, NSC-758954, [phenyl(4-phenylphenyl)methyl]imidazole, MRF-0000274, NCGC00018254-02, NCGC00018254-04, NCGC00018254-05, NCGC00018254-08, NCGC00089815-02, NCGC00089815-03, NCGC00089815-04, 1-[biphenyl-4-yl(phenyl)methyl]imidazole, AC-15414, AK158970, AN-39438, BC209083, LS-78073, SAM001246775, SC-77631, SBI-0206755.P001, 1-(.alpha.-(4-Biphenylyl)benzyl)imidazole, 1-(ALPHA,4-DIPHENYLBENZYL)IMIDAZOLE, 1-[alpha-(4-biphenylyl)-benzyl]-imidazole, AB0011811, AB2000334, ST2403297, TL8003842, (Biphenyl-4-yl)-imidazol-1-yl-phenylmethane, B4173, FT-0652733, ST50993921, SW197623-3, VU0239694-7, 28B968, D01775, Imidazole, 1-(.alpha.-(4-biphenylyl)benzyl)-, AB00383029-16, AB00383029_17, AB00383029_18, (.+/-.)-1-(p,.alpha.-Diphenylbenzyl)imidazole, A832816, 1-(1-Biphenyl-4-yl-2-phenyl-methyl)-1H-imidazole, I01-2098, Q-200717, SR-01000003136-4, SR-01000003136-6, BRD-A94543220-001-02-3, BRD-A94543220-001-12-2, 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole (bifonazole), 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole( Bifanozole), 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole(Bifonazole), 1-[[1,1'-Biphenyl]-4-yl(phenyl)methyl]-1H-imidazole #, Bifonazole, European Pharmacopoeia (EP) Reference Standard, 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-, (.+/-.)-, Bifonazole, Pharmaceutical Secondary Standard; Certified Reference Material, Bifonazole for system suitability, European Pharmacopoeia (EP) Reference Standard, Bifokey, Bifomyk, Moldina, Bifon, bicalutamide, bifazol, null, Bitrazepan, Canespor (TN), (+-)-Bifonazole, (+-)-Bifonazol, A-One-L, Bifonazole, 99% 1g, Canesten Extra Bifonazol, Bayer brand of bifonazole, UNII-QYJ305Z91O, D0AA2D, Bioglan brand of bifonazole, Inkeysa brand of bifonazole, Canesten brand of bifonazole, Juventus brand of bifonazole, Dermapharm brand of bifonazole, QYJ305Z91O, BAY-h 4502, Bifonazole (JP15/USAN/INN), CID2378, Merck Lipha Sante brand of bifonazole, C22-H18-N2, CS-O-06177, 1-[(4-Biphenylyl)phenylmethyl]-1H-imidazole, 1-((4-biphenylyl)-phenylmethyl)-1H-imidazole, C036596, 1H-imidazol, 1-([1,1'-bifenilo]-4-ilfenilmetil)-, (+-)-1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole, 91487-85-3,

Complexity	362
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	310.147g/mol
Formal Charge	0
Heavy Atom Count	24
Hydrogen Bond Acceptor Count	1
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	310.4g/mol
Monoisotopic Mass	310.147g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	17.8A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	4.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number